Myriad Genetics | MYGN - Market Capitalization

Myriad Genetics reported $1.93B in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Market Capitalization Change
Accelerate Diagnostics AXDX:US USD 152M 73M
Agilent A:US USD 44.31B 8.32B
Becton, Dickinson and BDX:US USD 72.06B 8.51B
Bio Rad Laboratories BIO:US USD 12.46B 64M
Biocept BIOC:US USD 16M 0
Bruker BRKR:US USD 10.05B 2.19B
Danaher DHR:US USD 193.22B 5.32B
Exact Sciences EXAS:US USD 8.8B 3.05B
Fluidigm FLDM:US USD 93M 6M
Hologic HOLX:US USD 18.39B 2.28B
Illumina ILMN:US USD 31.81B 1.83B
Johnson & Johnson JNJ:US USD 461.85B 32.35B
Mettler Toledo International MTD:US USD 32.22B 8.06B
Myriad Genetics MYGN:US USD 1.18B 363M
Nanostring Technologies NSTG:US USD 372M 222M
Orasure Technologies OSUR:US USD 350M 75M
Pacific Biosciences Of California PACB:US USD 1.85B 545M
Perkinelmer PKI:US USD 17.71B 2.52B
Quest Diagnostics DGX:US USD 17.82B 3.83B
Quidel QDEL:US USD 5.66B 872M
Repligen RGEN:US USD 9.4B 982M
Thermo Fisher Scientific TMO:US USD 215.98B 17.27B
Veracyte VCYT:US USD 1.7B 515M
Waters WAT:US USD 20.35B 4.21B